饮食,营养供应,以及瘤免疫反应
Claire L McIntyre1, Ayantu Temesgen1, Lydia Lynch2
1Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Trends in cancer
|July 3, 2023
概括
饮食影响瘤微环境 (TME) 中免疫细胞的营养可用性. 了解这些饮食影响可以增强抗瘤免疫力和癌症疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
- 癌症研究 癌症研究
背景情况:
- 免疫细胞需要特定的营养来有效地在瘤微环境 (TME) 中发挥作用.
- TME呈现出独特的营养条件,挑战免疫细胞代谢.
- 在瘤细胞和免疫细胞之间存在对营养素的竞争.
研究的目的:
- 讨论营养的可用性对瘤内的免疫功能的影响.
- 为了探索癌症和免疫细胞之间的营养竞争.
- 检查饮食如何影响这些相互作用和抗瘤免疫力.
主要方法:
- 文献综述和对TME中营养代谢的当前研究的综合.
- 免疫细胞代谢适应策略的分析.
- 调查饮食干预措施及其对抗瘤反应的影响.
主要成果:
- 营养素的可用性显著调节了TME中的免疫细胞效应器功能.
- 饮食模式可以改变营养竞争的平衡,有利于抗瘤免疫力.
- 特定的饮食修改显示了增强免疫媒介癌症控制的潜力.
结论:
- 饮食干预是传统癌症治疗的有希望的辅助策略.
- 调节营养的可用性可以优化抗瘤免疫反应.
- 对基于饮食的策略的进一步研究可能会彻底改变癌症治疗.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.6K
06:16Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
12.8K
相关概念视频
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cytotoxic T Cells-mediated Immune Response
995
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
995
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
